Arcturus Therapeutics Holdings Inc.
ARCT
Revenue
49.86M
▲11.85M▲31.17%
3 Months ChangeAssets
388.61M
▼-30.24M▼-7.22%
3 Months ChangeLiabilities
130.03M
▼-24.85M▼-16.05%
3 Months ChangeFree Cash Flow
-5.80M
▲30.77M▲84.14%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-08-13
Form 8-K
ID: 0001193805-24-001023
2024-08-05
Form 10-Q
ID: 0000950170-24-090905
2024-08-05
Form 8-K
ID: 0001193805-24-000990
2024-06-24
Form 8-K
ID: 0001193805-24-000842
2024-06-14
Form 8-K
ID: 0001193805-24-000806
2024-05-08
Form 10-Q
ID: 0000950170-24-055702
2024-05-08
Form 8-K
ID: 0001193805-24-000614
2024-04-05
Form 8-K
ID: 0001193805-24-000505
2024-03-19
Form 8-K
ID: 0001193805-24-000392
2024-03-07
Form 8-K
ID: 0001193805-24-000335